Skip to main content

$2.00 0.07 (3.36%)

High

$2.02

Low

$1.95

Trades

7

Turnover

$14,184

Volume

7,103
30 June 2023 at 3:19pm
Register to track CYC and receive email alerts.
Subject
CYC Ann: Notification of buy-back - CYC

CYC Ann: Results of Meeting

CYC Ann: Managing Director's Address to Shareholders

CYC Ann: CYC 2023 AGM Presentation

CYC Ann: Chairman's Address to Shareholders

CYC Ann: Cyclopharm Confirms USFDA Scheduled Inspection Date

CYC Ann: USFDA Confirms Technegas Six Month Review Period

CYC Ann: Cyclopharm Acquires DuPharma ApS

CYC Ann: Application for quotation of securities - CYC

CYC Ann: Proposed issue of securities - CYC

CYC Ann: Notice of Annual General Meeting/Proxy Form

CYC Ann: Cyclopharm USFDA Approval Progress Update

CYC Ann: Appendix 4G

CYC Ann: Annual Report to shareholders

CYC Ann: Technegas Enters Final Six Month USFDA Review Cycle

CYC Ann: Application for quotation of securities - CYC

CYC Ann: Date of Annual General Meeting

CYC Ann: CYC Results Summary

CYC Ann: Preliminary Final Report

CYC Ann: Dividend/Distribution - CYC

CYC Ann: Change of Director's Interest Notice - KBarrow

CYC Ann: Change of Director's Interest Notice - DAngus

CYC Ann: Cyclopharm Receives $1.64m R&D Refund

CYC Ann: Bell Potter Healthcare Conference Directors Profile

CYC Ann: Bell Potter Healthcare Conference

CYC Ann: Notification of cessation of securities - CYC

CYC Ann: CYC Board Changes

CYC Ann: Initial Director's Interest Notice

CYC Ann: Initial Director's Interest Notice

CYC Ann: CYC Board Changes

CYC Ann: Half Year 2022 Results

CYC Ann: Half Yearly Report and Accounts

CYC Ann: Dividend/Distribution - CYC

CYC Ann: Technegas Used In Multicenter COVID Study

CYC Ann: 1H 2022 Business Update - Record Revenues

CYC Ann: Change of Director's Interest Notice

CYC Ann: CYC Investor Presentation 24 May 2022

CYC Ann: Technegas used in Diagnosing Long COVID

CYC Ann: Change of Director's Interest Notice

CYC Ann: Results of Meeting

CYC Ann: Managing Director's Address to Shareholders

CYC Ann: CYC 2022 AGM Presentation

CYC Ann: Chairman's Address to Shareholders

CYC Ann: Notice of Annual General Meeting/Proxy Form

CYC Ann: Appendix 4G

CYC Ann: Annual Report to shareholders

CYC Ann: Date of Annual General Meeting

CYC Ann: Change of Director's Interest Notice

CYC Ann: S&P DJI Announces March 2022 Quarterly Rebalance

CYC Ann: CYC Results Summary

Register to track CYC and receive email alerts.

Similar Companies

AT1
COH
CSX
EMV
IBX
IPD
MX1
RSH
SOM